Upcoming Event: 5th Product And Pipeline Enhancement For Generics 06/06/2012 by Intellectual Property Watch Leave a Comment A conference entitled the “5th Product and Pipeline Enhancement for Generics” to be held in Washington, DC on 17-19 July will feature industry leaders in the generic, branded pharmaceutical and API industries. Issues covered will include current and upcoming changes in regulations and the market, innovation in drug pipeline, portfolio management and business development, intellectual property protection and biosimilars.
IP5 Patent Offices Strengthen Joint Work 06/06/2012 by Intellectual Property Watch Leave a Comment The heads of the world’s five largest intellectual property offices, who refer to themselves as the IP5, met today to discuss further efforts to improve quality and efficiency in patent examination, and harmonise patent systems. Joining them were industry representatives from each of the regions.
European Nuclear Lab CERN Launches New “Easy IP” Plan 04/06/2012 by William New, Intellectual Property Watch 2 Comments Does the idea of a multifunctional, versatile position-sensitive detector for measuring characteristics of a beam of particles spark ideas for useful products of benefit to society and the economy? If so, then CERN has just the thing for you. In an attempt to boost the utility of its research, the European Organization for Nuclear Research (CERN), the Geneva-based intergovernmental laboratory, today announced a plan to offer its patented technologies for licence royalty-free in order to promote innovation.
Asian Governments Plan To Better Use TRIPS Flexibilities For Health 01/06/2012 by William New, Intellectual Property Watch 2 Comments International trade rules related to intellectual property rights enshrine the notion that there may be cases where exceptions to IP rights are needed by governments, such as sovereign decisions on a nation’s public health. Using those flexibilities could save millions of lives but may mean taking a tough stance in free trade negotiations with bigger trading partners, concluded a meeting of Asian stakeholders this week.
ICANN To Reveal New Internet Domain Applications In Mid-June 01/06/2012 by Intellectual Property Watch Leave a Comment The Internet Corporation for Assigned Names and Numbers (ICANN), the domain name system technical oversight body, will shortly make public the list of applied for new domains.
MSF Medicines Access Campaign Director Departs; New Director Named 31/05/2012 by William New, Intellectual Property Watch Leave a Comment Médicins Sans Frontières (MSF, Doctors without Borders) announced today that it has named a new executive director of its Access to Medicines Campaign, a high-impact advocacy initiative on international public health issues in Geneva and elsewhere. Today was the last day for current Executive Director Tido von Schoen-Angerer, who completed two three-year terms in the role.
World Health Assembly: Agreement Reached On Neglected Disease R&D Process, But No Convention 25/05/2012 by William New, Intellectual Property Watch 8 Comments A proposal at this week’s World Health Assembly to negotiate a binding convention on research and development for neglected diseases – those predominantly afflicting poor populations – ran into resistance from developed countries which hold the view that another approach might be possible. But an agreement was reached on a way forward for the expert report that recommended the binding convention.
World Health Assembly: Latest Texts Of R&D Drafting Group 25/05/2012 by Intellectual Property Watch Leave a Comment The latest available documents of the closed-door meeting addressing recommendations on ways to finance neglected diseases largely afflicting developing countries show progress heading into this afternoon’s session. They reflect efforts to agree on how to take the process forward, including agreement reached last night on putting the issue to regional groups later this year.
World Health Assembly: R&D Drafting Group Documents Show Country Differences 24/05/2012 by William New, Intellectual Property Watch 1 Comment A set of documents in use by today’s closed-door negotiations on research and development for neglected diseases at the World Health Assembly lay out the core differences between WHO members. Negotiations are expected to last into the night as members try to agree on how to take forward recommendations from a key report – including to negotiate a binding convention on R&D for diseases left behind in the marketplace.
World Health Assembly Draft Decision On NCDs 24/05/2012 by Intellectual Property Watch 2 Comments Members of the World Health Organization tonight will consider a draft decision on how the organisation will address the prevention and control of noncommunicable diseases, such as tobacco use, unhealthy diet, physical inactivity and harmful use of alcohol.